MValve technologies

Mitral Regurgitation Solution

Health Tech & Life Sciences

Non Active, Oct 2018 ceased to operate

Seed Herzliya Founded 2011

Total raised

$200.0M

Last: Undisclosed 2015-10

Stage

Seed

Founded

2011

Headcount

Herzliya

Sector

Health Tech & Life Sciences

About

MValve technologies is dedicated to providing a solution for mitral regurgitation, an abnormal reversal of blood flow from the hearts left ventricle to the left atrium.

Funding history · 2 rounds · $200.0M total

2015-10

Undisclosed $200.0M

2014-07

Debt Financing $15.0M

Sectors & technology

Primary sector

Health Tech & Life Sciences

Sub-sectors

Health Tech & Life SciencesMedical DevicesLife SupportMedical Treatment & Therapeutics

Technologies

Materials & SubstancesImplants

Target customers

Healthcare & Life SciencesHealthcareProviders

Business model

B2B

Highlights

1 Patents

Name	MValve technologies
Slug	mvalve-technologies
Type	Israeli Startup
Founded	2011
HQ city	Herzliya
HQ country	IL
Primary sector	[object Object]
Sectors	[object Object], [object Object], [object Object], [object Object]
Business models	B2B
Target customers	[object Object], [object Object], [object Object]
Status	inactive
Current stage	Seed
Public stage	Seed
Total raised (USD)	200,000,000
Last round	Undisclosed (2015-10)
Crunchbase ID	mvalve-technologies
Israeli Companies Registrar	514696004

Date	Round	Amount	Lead investors	All investors	Valuation
2014-07	Debt Financing	$15,000,000		BSC International Holding Ltd
2015-10	Undisclosed	$200,000,000

Name	Role	LinkedIn
Assif Stoffman
Maurice Buchbinder

MValve technologies

About

Funding history · 2 rounds · $200.0M total

Sectors & technology

Highlights

Tags